Biography
Dr. Cheryl Ewing is Associate Professor of Surgery at UCSF Mount Zion Hospital. Her focus is in breast cancer surgery and sentinel lymph node dissection. Her other interests include quality of care and evaluation of barriers to medical and breast care for minority women.
Dr. Ewing completed her undergraduate education at the University of Michigan, and received her medical degree from Wayne State University School of Medicine. She then went on to complete her residency at University of Michigan Medical School, and then her fellowship at the University of Chicago. She joined the faculty at UCSF in 2001.
Dr. Ewing has lectured extensively at many local, national, and international events. She has been very active in mentoring residents and fellows, serving four years as the Mount Zion Site Director for the Surgery 110 Rotations and teaching several CME courses and Grand Rounds.
Dr. Ewing is involved in several studies involving quality of care among breast cancer survivors. Specifically, these involve post-surgery symptom management, and customizing risk assessment and tailoring treatment to the individual patient's medical profile and preferences. Her primary focus in on how being a breast cancer survivor affects the quality of life in different race/ethnic groups, and how that relationship is modified by social support, depression, and spirituality.
Dr. Ewing is a member of most of the major surgical societies, and has been the recipient of several awards, including the Susan G. Komen Local Hero Award.
Education
Education
- 1978-83, Wayne State University School of Medicine, MD
Residencies
- 1983-88, St. Joseph Mercy Hospital, University of Michigan Medical School
Fellowships
- 1988-91, Surgical Oncology Fellow, University of Chicago
Board Certifications
- 1984, American Board of Surgery
- 1998, American Board of Surgery
Program Affiliations
- UCSF Helen Diller Family Comprehensive Cancer Center
Research Interests
- Mastectomy
- Sentinel Lymph Node Biopsy
- Ductal Carcinoma In Situ (DCIS)
- Minority Health
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 58
- Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes.| | View in PubMed
- Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy.| | View in PubMed
- Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.| | View in PubMed
- Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 Trial.| | View in PubMed
- Expanding Candidacy for Nipple-sparing Mastectomy in Women with Large or Ptotic Breasts: Staged Reconstruction Outcomes.| | View in PubMed
- Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial.| | View in PubMed
- Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.| | View in PubMed
- Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: Incidence and management strategies.| | View in PubMed
- Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma.| | View in PubMed
- Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast: Factors associated with false negatives.| | View in PubMed
- Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience.| | View in PubMed
- Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast.| | View in PubMed
- Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater.| | View in PubMed
- Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival.| | View in PubMed
- Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast.| | View in PubMed
- Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer.| | View in PubMed
- Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.| | View in PubMed
- Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.| | View in PubMed
- Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients.| | View in PubMed
- Complications After Total Skin-Sparing Mastectomy and Expander-Implant Reconstruction: Effects of Radiation Therapy on the Stages of Reconstruction.| | View in PubMed
- Indications for Postmastectomy Radiation After Neoadjuvant Chemotherapy in ypN0 and ypN1-3 Axillary Node-Positive Women.| | View in PubMed
- Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.| | View in PubMed
- The Impact of Radiation Therapy, Lymph Node Dissection, and Hormonal Therapy on Outcomes of Tissue Expander-Implant Exchange in Prosthetic Breast Reconstruction.| | View in PubMed
- Tissue Expander Reconstruction After Total Skin-Sparing Mastectomy: Defining the Effects of Coverage Technique on Nipple/Areola Preservation.| | View in PubMed
- Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome.| | View in PubMed
- Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer.| | View in PubMed
- Expanding the Indications for Total Skin-Sparing Mastectomy: Is It Safe for Patients with Locally Advanced Disease?| | View in PubMed
- Tumor Involvement of the Nipple in Total Skin-Sparing Mastectomy: Strategies for Management.| | View in PubMed
- Rates of Reconstruction Failure in Patients Undergoing Immediate Reconstruction With Tissue Expanders and/or Implants and Postmastectomy Radiation Therapy.| | View in PubMed
- The impact of breast mass on outcomes of total skin-sparing mastectomy and immediate tissue expander-based breast reconstruction.| | View in PubMed
- Immediate implant-based breast reconstruction following total skin-sparing mastectomy: defining the risk of preoperative and postoperative radiation therapy for surgical outcomes.| | View in PubMed
- Total skin-sparing mastectomy and immediate breast reconstruction: an evolution of technique and assessment of outcomes.| | View in PubMed
- Immediate implant-based breast reconstruction following total skin-sparing mastectomy in women with a history of augmentation mammaplasty: assessing the safety profile.| | View in PubMed
- Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657).| | View in PubMed
- Abstract 124: outcomes of total skin-sparing mastectomy and reconstruction in 924 breasts over 11 years.| | View in PubMed
- Total skin-sparing mastectomy in BRCA mutation carriers.| | View in PubMed
- Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomy.| | View in PubMed
- The effects of acellular dermal matrix in expander-implant breast reconstruction after total skin-sparing mastectomy: results of a prospective practice improvement study.| | View in PubMed
- Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts.| | View in PubMed
- The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ.| | View in PubMed
- Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience.| | View in PubMed
- Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction.| | View in PubMed
- Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins?| | View in PubMed
- Bacteriologic features of surgical site infections following breast surgery.| | View in PubMed
- Emotion work: disclosing cancer.| | View in PubMed
- Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancer.| | View in PubMed
- Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients.| | View in PubMed
- Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer?| | View in PubMed
- Surgery for palliation and treatment of advanced breast cancer.| | View in PubMed
- Ethnicity and spirituality in breast cancer survivors.| | View in PubMed
- Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.| | View in PubMed
- The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.| | View in PubMed
- Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients.| | View in PubMed
- MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.| | View in PubMed
- Safety of immediate transverse rectus abdominis myocutaneous breast reconstruction for patients with locally advanced disease.| | View in PubMed
- Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation.| | View in PubMed
- Nonepithelial malignancies mimicking primary carcinoma of the breast.| | View in PubMed
- Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer.| | View in PubMed